Skip to content

ARCT - Arcturus Therapeutics Holdings Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Arcturus Therapeutics Holdings Inc

ARCT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ARCTArcturus Therapeutics Holdings Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $24.17
52-wk low: $5.50
Prev close: $14.03
Mkt cap: $292.2M
Fwd P/E: 2.5x
Beta: 2.27

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$59.2M

CW
Cathie Wood
Q2 2026 13F
$19.5M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 21.5% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 2.48
Market cap: $292M

Valuation

P/S9.95
P/B1.36

Quality

Operating margin-863.0%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ARCT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $292.19M
Beta: 2.27

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

9.9x

P/B

1.4x

Profit margin

+0.0%

Op margin

-863.0%

ROE

-46.3%

$7.3M

position

AQ

AQR

Q2 2026 13F

$4.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ARCT

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.84+21.5%

-$1.07 expected

Next report

What the street expects next

EPS expected

-$0.67

-$0.92 to -$0.29

Revenue expected

$8.0M

13 analysts

Last 30 days

6up3down

Analysts raising estimates

Estimate drift

+0.21

Change in 30 days

ROE

-46.3%

ROA-24.0%

Growth

Beta2.27